Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the page.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3; no visible changes to study content or navigation.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded site revision tag v3.4.2; removed the government funding operating-status notice, and these changes do not affect the study details or eligibility information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedA site-wide government funding status notice has been added and the site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check69 days agoChange DetectedGlossary toggle added and metadata labels updated (QC criteria status wording and revision version). These are administrative updates that do not alter core study content, eligibility, or results.SummaryDifference0.2%

- Check83 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.